SPOTLIGHT -
Rapid Diagnostics for Gram-Negative Bloodstream Infections
Kimberly Claeys, PharmD, discusses the need for more data on rapid diagnostics for gram-negative bloodstream infections.
Read More
The ID Pipeline: FDA Activity From the Week of June 9, 2019
Here is a look at infectious disease-related US Food and Drug Administration news from the week of June 9, 2019.
Recalls That Should Be on Your Radar—Week of June 9, 2019
We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.
Top Infectious Disease News of the Week—June 9, 2019
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
What to Expect in June's Editor-in-Chief Letter
Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, previews his editor-in-chief letter for the June issue.
The ID Pipeline: FDA Activity From the Week of June 2, 2019
Here is a look at infectious disease-related US Food and Drug Administration news from the week of June 2, 2019.
Recalls That Should Be on Your Radar—Week of June 2, 2019
Top Infectious Disease News of the Week—June 2, 2019
What to Expect in June's Multidrug-Resistant Infections Section of Contagion®
Ryan K. Shields, PharmD, MS, Contagion®'s Multidrug-Resistant Infections Section Editor, previews the upcoming June issue.
FDA Approves Ceftolozane/Tazobactam for HABP/VABP
In addition to cUTI and cIAI, ceftolozane/tazobactam (Zerbaxa) is now approved to treat hospital-acquired/ventilator-associated bacterial pneumonia.
The ID Pipeline: FDA Activity From the Week of May 26, 2019
Here is a look at infectious disease-related US Food and Drug Administration news from the week of May 26, 2019.
Recalls That Should Be on Your Radar—Week of May 26, 2019
Top Infectious Disease News of the Week—May 26, 2019
May 360: Trending Infectious Disease News of the Month
As May draws to a close, the Contagion® editorial staff is recapping the trends and top infectious disease news of the month.
What to Expect in June's In the Literature
Section Editor, Monica Mahoney, PharmD, shares a preview of the June issue of Contagion.
The ID Pipeline: FDA Activity From the Week of May 19, 2019
Here is a look at infectious disease-related US Food and Drug Administration news from the week of May 19, 2019.
Recalls That Should Be on Your Radar—Week of May 19, 2019
Top Infectious Disease News of the Week—May 19, 2019
Time to Clinical Response as a Valuable Metric
Thomas Lodise, PharmD, PhD, discusses why "time to clinical response" is a valuable metric to use in clinical studies.
The ID Pipeline: FDA Activity From the Week of May 12, 2019
Here is a look at infectious disease-related US Food and Drug Administration news from the week of May 12, 2019.
Recalls That Should Be on Your Radar—Week of May 12, 2019
Top Infectious Disease News of the Week—May 12, 2019
Amy Fabian, PharmD, BCPS: Pharmacist Impact on Antimicrobial Prescribing in Outpatient Setting
Does pharmacist presence in an urgent care center have an effect on antibiotic prescribing practices?
Jason Gallagher, PharmD, on New Gram-Negative Agents and Practical Micro Lab Interventions
Contagion® editor-in-chief Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, recaps his presentations from MAD-ID 2019.
Ryan K. Shields, PharmD, MS: T2Candida's Place in Rational Antifungal Management
Ryan K. Shields, PharmD, MS, discusses his research presented at MAD-ID 2019 on T2Candida's place in rational antifungal management.
Why It's Important to Continue to Develop New Antifungals
Minh-Hong Nguyen, MD, explains why it's so important to continue developing new antifungal drugs.
The ID Pipeline: FDA Activity From the Week of May 5, 2019
Here is a look at infectious disease-related US Food and Drug Administration news from the week of May 5, 2019.
Recalls That Should Be on Your Radar—Week of May 5, 2019
Top Infectious Disease News of the Week May 5, 2019
Contagion® to Report on MAD-ID 2019 in Orlando
Contagion® will be heading to Orlando, Florida, on Wednesday, May 8, 2019, to report on the annual Making a Difference in Infectious Diseases (MAD-ID) 2019 conference.